2026
-
Experts Encourage ATS Attendees to Take Action for Air Quality at Tuesday’s Keynote
on
Read more: Experts Encourage ATS Attendees to Take Action for Air Quality at Tuesday’s KeynoteA panel of experts challenged ATS members and ATS 2025 International Conference attendees to help patients and regional leaders understand and act on the increasing importance of air quality for individuals and community health during the Keynote Series session, “Improving Air Quality and Health: Current Challenges and Opportunities.”
-
President’s Symposium Explores Many Facets of Underdiagnosed Alpha-1 Antitrypsin Deficiency
on
Read more: President’s Symposium Explores Many Facets of Underdiagnosed Alpha-1 Antitrypsin DeficiencyThe “ATS President’s Symposium: Alpha-1 Breakthroughs: New Discoveries in Mechanisms, Diagnosis & Treatment of Lung Disease in Alpha-1 Antitrypsin Deficiency” examined critical gaps in knowledge about the disease at ATS 2025 San Francisco.
-
Pitch for Incentive Spirometry Device Wins 2025 BEAR Cage Competition
on
Read more: Pitch for Incentive Spirometry Device Wins 2025 BEAR Cage CompetitionYi-an Hsieh, MSE, and Joshua Freedman, MSE, co-founders of Airalux Medical, won the ATS 2025 BEAR Cage competition and a $10,000 prize at ATS 2025 San Francisco for their pitch, “Digital Incentive Spirometer to Improve Patient Adherence and Clinical Workflows.”
-
Early Career Programs Connect and Enrich Next Generation of Respiratory Medicine Professionals
on
Read more: Early Career Programs Connect and Enrich Next Generation of Respiratory Medicine ProfessionalsMore than 500 students and young professionals pursuing a career in pulmonary, critical care, and sleep medicine converged in San Francisco to attend the Early Career Programs at the ATS 2025 International Conference, where they learned about the latest technologies, scientific discoveries, and guidelines in the field.
-
Monday Keynote Presents Exciting Progress in Gene Therapies for Cystic Fibrosis
on
Read more: Monday Keynote Presents Exciting Progress in Gene Therapies for Cystic FibrosisEric Alton, MD, led a Keynote Series session at the ATS 2025 International Conference, sharing breakthroughs and challenges of targeted gene therapies for cystic fibrosis and exploring subsequent applications for other respiratory diseases.
-
Amberson, Trudeau, Distinguished Achievement Honorees Inspire with Words of Encouragement and Details of Their Respiratory Health Wins
on
Read more: Amberson, Trudeau, Distinguished Achievement Honorees Inspire with Words of Encouragement and Details of Their Respiratory Health WinsWhile their groundbreaking contributions to respiratory medicine were in the spotlight during the Respiratory Health Awards Ceremony at ATS 2025 San Francisco, awardees also shared inspirational messages for career success and overcoming challenging times.